CT-2584 in Treating Patients With Metastatic Prostate Cancer That Has Not Responded to Previous Therapy
Summary
The lay summary the sponsor registered on ClinicalTrials.gov.
Investigators
The overall officials registered on this study. Names that resolve to a FindMyKOL profile link to it; the rest are shown as registered.
- Carolyn Paradise, MD
CTI BioPharma
Study Chair
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
7 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Jonsson Comprehensive Cancer Center, Ucla
Los Angeles, California, United States
- Ucsf Cancer Center and Cancer Research Institute
San Francisco, California, United States
- Stanley Scott Cancer Center
New Orleans, Louisiana, United States
- Johns Hopkins Oncology Center
Baltimore, Maryland, United States
- Herbert Irving Comprehensive Cancer Center
New York, New York, United States
- Our Lady of Mercy Medical Center
The Bronx, New York, United States
- University of Washington Medical Center
Seattle, Washington, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
The drug and biological interventions registered on this study, normalized to their RxNorm ingredient where possible.
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 31 Dec 1998
- Primary completion
- 31 Jan 2005
- Completion
- 31 Jan 2005
- Last update posted
- 19 Oct 2020
- Registered enrollment
- 80
- Registry id
- NCT00004026
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 18 Nov 2026. Registry facts are shown as registered by the study sponsor; FindMyKOL does not interpret them.